Pateres, Mhark Ghiell R.

HRN: 22-24-69  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2023
AMPICILLIN 500MG (VIAL)
01/14/2023
01/20/2023
IVT
300mg
Q6 X 7 Days
For Liver Pathology; Pneumonia
Waiting Final Action 
01/14/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/14/2023
01/20/2023
IVT
15mg
Q24 X 7 Days
Pneumonia; Liver Pathology
Waiting Final Action 
01/20/2023
CEFTAZIDIME 1GM (VIAL)
01/20/2023
01/27/2023
INTRAVENOUS
150 Mg
Q8h
Sepsis, Unspecified
Waiting Final Action 
01/20/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/21/2023
01/23/2023
INTRAVENOUS
15 Mg
Q24 X 3 Days
Sepsis, Unspecified
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: